Diagnostic of Biological Agents Allergy
Treatment of Biological Agents Allergy
Allergy immunotherapy, commonly known as allergy shots, is a well-established treatment for individuals suffering from allergies to biological agents. This therapy involves a series of injections with gradually increasing doses of the allergen molecule.
Initial Phase: In the beginning, patients receive shots with a very low dose of the allergen, administered once or twice a week. This phase typically lasts for three to six months.
Maintenance Phase: Once the optimal dose is achieved, the frequency of the injections decreases to every two to four weeks. This phase can last from three to five years or longer, depending on the individual's response.
Effectiveness: Over time, allergy immunotherapy can lead to lasting remission of allergy symptoms even after the treatment has ended. Most patients start to notice improvement within the first year of treatment.
Benefits: Immunotherapy is a targeted approach that helps in reducing the severity of symptoms and the need for medications. Additionally, it has the potential to prevent the development of new allergies and the progression from allergic rhinitis to asthma.
Precautionary Measures: The treatment should always be carried out under the supervision of a qualified healthcare professional, as there is a small risk of adverse reactions, including anaphylaxis.
Through consistent administration and careful monitoring, allergy immunotherapy offers a promising path to desensitizing the immune system to the offending biological agents, thereby significantly improving quality of life for allergy sufferers.